Position history for ADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in ROYALTY PHARMA PLC
ADAGE CAPITAL PARTNERS GP, L.L.C. holds 11.7M shares of RPRX (ROYALTY PHARMA PLC), worth $453.7M as of 2025-Q4. The position was decreased (-1.9% shares). RPRX represents 0.7% of ADAGE CAPITAL PARTNERS GP, L.L.C.'s portfolio.
Current Value
$453.7M
Current Shares
11.7M
Total Value Change
+$165.4M
Total Shares Change
+808,663
Other major holders of RPRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 11.7M |
-1.9% |
| $453.7M |
| 0.7% |
| $38.99 |
0 |
| 2025-Q3 | Increased | 12M | +99.4% | $422.1M | 0.7% | $35.05 | 71 |
| 2025-Q2 | Decreased | 6M | -4.0% | $216.2M | 0.4% | $35.46 | 0 |
| 2025-Q1 | Decreased | 6.3M | -63.2% | $194.6M | 0.4% | $30.80 | 0 |
| 2024-Q4 | Increased | 17M | +42.6% | $432.9M | 0.8% | $24.70 | 59 |
| 2024-Q3 | Increased | 11.9M | +8.8% | $336.6M | 0.6% | $27.29 | 48 |
| 2024-Q2 | Increased | 10.9M | +1.1% | $288.3M | 0.5% | $25.32 | 44 |